Search Results - "Venter, Esme"

Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study by Rodriguez, Carina A, Natukunda, Eva, Strehlau, Renate, Venter, Esme L, Rungmaitree, Supattra, Cunningham, Coleen K, Lalloo, Umesh, Kosalaraksa, Pope, HellstrÖm, Elizabeth, Liberty, Afaaf, McGrath, Eric J, Kaur, Meenu, Leisegang, Rory, Hindman, Jason T, Vieira, Vinicius A, Kersey, Kathryn, Cotton, Mark F, Rakhmanina, Natella, Gaur, Aditya H

“…Coformulated bictegravir, emtricitabine, and tenofovir alafenamide is a single-tablet regimen and was efficacious and well tolerated in children and…”
Get full text

Immunogenicity and safety of SARS-CoV-2 recombinant spike protein vaccine in South African people living with and without HIV-1 infection: A phase 2 randomised trial by Bennett, Chijioke, Hoosain, Zaheer, Koen, Anthonet, Lalloo, Umesh, Louw, Cheryl, Maluleke, Vongane, Patel, Faeezah, Benade, Gabriella, Venter, Esme Louise, Galbiati, Shirley, Shinde, Vivek, Madhi, Shabir A.

“…Response data for COVID-19 vaccines in immunosuppressed individuals are typically limited to standard dosing in small populations. Adjusting number or interval…”
Get full text